Middle East & Africa Viral Vector Market Size & Outlook

The viral vector market in Middle East & Africa is expected to reach a projected revenue of US$ 158.8 million by 2033. A compound annual growth rate of 6.9% is expected of Middle East & Africa viral vector market from 2026 to 2033.
Revenue, 2025 (US$M)
$93.8
Forecast, 2033 (US$M)
$158.8
CAGR, 2026 - 2033
6.9%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa viral vector market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA viral vector market highlights

  • The MEA viral vector market generated a revenue of USD 93.8 million in 2025.
  • The market is expected to grow at a CAGR of 6.9% from 2026 to 2033.
  • In terms of segment, adeno associated virus (aav) was the largest revenue generating vector type in 2025.
  • Adeno associated virus (AAV) is the most lucrative vector type segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2026 to 2033.


MEA data book summary

Market revenue in 2025USD 93.8 million
Market revenue in 2033USD 158.8 million
Growth rate6.9% (CAGR from 2026 to 2033)
Largest segmentAdeno associated virus (aav)
Fastest growing segmentAdeno associated virus (AAV)
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAdeno associated virus (AAV), Adenovirus, Lentivirus, Retrovirus, Other Vector Type
Key market players worldwideOxford Biomedical Research, Lonza Group Ltd, Thermo Fisher Scientific Inc, Biogen Inc, Roche Holding AG, Regenxbio Inc, UniQure NV, Bayer AG, Sanofi SA, Batavia Biosciences


Other key industry trends

  • In terms of revenue, MEA region accounted for 2.2% of the global viral vector market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,178.9 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viral Vector Market Companies

Name Profile # Employees HQ Website
Batavia Biosciences View profile 101-250 Leiden, Zuid-Holland, The Netherlands, Europe http://www.bataviabiosciences.com/
Regenxbio Inc View profile 344 9804 Medical Center Drive, Rockville, MD, United States, 20850 https://www.regenxbio.com
Oxford Biomedical Research View profile 11-50 Rochester Hills, Michigan, United States, North America https://www.oxfordbiomed.com/
Biogen Inc View profile 7570 225 Binney Street, Cambridge, MA, United States, 02142 https://www.biogen.com
UniQure NV View profile 480 Paasheuvelweg 25, Amsterdam, NH, Netherlands, 1105 BP https://www.uniqure.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com

Middle East & Africa viral vector market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector market will help companies and investors design strategic landscapes.


Adeno associated virus (aav) was the largest segment with a revenue share of 54.26% in 2025. Horizon Databook has segmented the Middle East & Africa viral vector market based on adeno associated virus (aav), adenovirus, lentivirus, retrovirus, other vector type covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Middle East & Africa viral vector market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa viral vector market databook

  • Our clientele includes a mix of viral vector market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa viral vector market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa viral vector market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA viral vector market size, by country, 2018-2030 (US$M)

Middle East & Africa Viral Vector Market Outlook Share, 2025 & 2033 (US$M)

MEA viral vector market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online